Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study.
Valacyclovir is effective for suppressive and episodic treatment of recurrent genital herpes. Few data on patients' treatment strategy preferences are available.
The goal was to assess patients' preference, satisfaction, and quality of life with suppressive versus episodic treatment of recurrent genital herpes.
This was a multicenter, open-label, randomized, two-arm, crossover 48-week study involving 225 patients with genital herpes.
Suppressive valacyclovir therapy was preferred to episodic valacyclovir treatment by 72% of patients (P
Notes
Comment On: Sex Transm Dis. 2003 Mar;30(3):232-312616142